Detalles de la búsqueda
1.
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project.
J Urol
; 199(2): 401-406, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28847481
2.
68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study.
J Urol
; 200(1): 95-103, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409824
3.
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.
BJU Int
; 115(4): 537-45, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130593
4.
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study.
BJU Int
; 115(6): 913-20, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24589357
5.
Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.
J Urol
; 190(2): 496-501, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23466239
6.
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
BJU Int
; 111(5): 723-30, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22487441
7.
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.
BJU Int
; 112(3): 313-21, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23826841
8.
Urethral lift for benign prostatic hyperplasia: a comprehensive review of the literature.
Curr Urol Rep
; 14(6): 620-7, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23794125
9.
The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review.
Diagnostics (Basel)
; 13(19)2023 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835862
10.
Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.
J Urol
; 188(4): 1144-50, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22901589
11.
Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy.
J Urol
; 188(4): 1137-43, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22901578
12.
The relationship between continence and perineal body tone before and after radical prostatectomy: a pilot study.
Neurourol Urodyn
; 31(4): 513-6, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22396354
13.
Early Catheter Removal After Robot-assisted Radical Prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study).
Eur Urol Focus
; 6(2): 259-266, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413390
14.
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer.
Eur Urol Oncol
; 2(3): 329-332, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200848
15.
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study.
Minerva Urol Nefrol
; 71(3): 273-279, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30700081
16.
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS.
Minerva Urol Nefrol
; 71(4): 406-412, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144485
17.
Re: "trifecta" in partial nephrectomy: A. J. Hung, j. Cai, M. N. Simmons and I. S. Gill j Urol 2013; 189: 36-42.
J Urol
; 190(2): 810-1, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23434941
18.
Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project.
Eur Urol Oncol
; 1(5): 437-442, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158085
19.
Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus
; 4(4): 558-567, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28753839
20.
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guérin: experience of a single center.
Minerva Urol Nefrol
; 70(5): 501-508, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29968999